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Abstract: Although ancient, heritage, and modern wheat varieties appear rather similar from a
nutritional point of view, having a similar gluten content and a comparable toxicity linked to
their undigested gluten peptide, whenever the role of ancient end heritage wheat grains has been
investigated in animal studies or in clinical trials, more anti-inflammatory effects have been associated
with the older wheat varieties. This review provides a critical overview of existing data on the
differential physiological responses that could be elicited in the human body by ancient and heritage
grains compared to modern ones. The methodology used was that of analyzing the results of relevant
studies conducted from 2010 through PubMed search, by using as keywords “ancient or heritage
wheat”, “immune wheat” (protein or peptides), and immune gluten (protein or peptides). Our
conclusion is that, even if we do not know exactly which molecular mechanisms are involved, ancient
and heritage wheat varieties have different anti-inflammatory and antioxidant proprieties with respect
to modern cultivars. It is, therefore, reasonable to assume that the health proprieties attributed to
older cultivars could be related to wheat components which have positive roles in the modulation of
intestinal inflammation and/or permeability.
Keywords: ancient and heritage wheat; gluten; immunogenic wheat peptides; gliadins; amylase
trypsin inhibitors (ATI); celiac disease
1. Introduction: Ancient, Heritage, and Modern Wheat Cultivars
Man first domesticated a diploid and tetraploid wheats about 10,000 years ago [1]. One of the wheat
originally domesticated is sometimes called “einkorn,” and it has only one genome, designated as A
genome. Since it is diploid, the plant genome designation is AA. The diploid wild wheat that was firstly
domesticated was subjected to a continuous breeding and selection, which reasonably would have
introduced and stabilized some new genes and/or controlling sequences into the genome. Consequently,
the modern domesticated diploid wheat should have significantly different characteristics from the wild
ones. The selection for the size of the seed, which occurred for a long time, certainly led to an increase
in the starch content at the expense of the protein content [2]. The domesticated diploid wheat, einkorn,
was designated Triticum monococcum by Linnaeus in the 18th century. The amount of T. monococcum
that is grown today is very small and only partially used for human consumption. Tetraploid wheat
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was likely domesticated about the same time as diploid wheat [1]. It has two genomes designated as
AABB. The A genome of the tetraploid wheats is closely similar to that of T. monococcum, while the B
genome has been attributed to Triticum speltoides. The wild tetraploids are often designated Triticum
dicoccoides, and the domesticated equivalents have been classified as Triticum turgidum. T. turgidum
has two subspecies/varieties, one with the common name emmer and the other called durum. The
main wheat of the Roman empire was emmer, and its modern cultivars are used for preparing human
food, mainly biscuits and pasta. Durum wheats are now used mainly for pasta, although bread can be
made from durum wheat, and such bread is still common in the south of Italy.
Hexaploid wheat has three genomes, designated A, B, and D. The A and B genomes of hexaploid
wheats are nearly identical to the A and B genomes of tetraploid wheat. The hexaploid wheats have
no wild equivalents and resulted from hybridization of a cultivated (domesticated) emmer and a
wild grass species known as Triticum tauschii [3]. It was called Triticum aestivum, and its genome
was designated AABBDD. These hexaploid wheats are free-threshing with the exception of spelt
wheat, which has tightly adhering glumes and probably arose a few thousand years after the first
wheat domestication.
There is evidence that the D genome of bread wheat has more epitopes active in Celiac Disease
(CD) than the A and B genomes, and some of these showed, at least in vitro, to be the most active
epitopes [4]. Consequently, diploid and tetraploid wheats (T. monococcum, for example) are likely
to be less toxic to celiac patients than bread wheats. However, given that all of these wheats have
proteins with several of the potentially active sequences that have been defined as toxic for people
with CD [5,6], the significant decreased number of epitopes present in diploid and tetraploid wheats it
is not sufficient to allow their consumption by affected subjects.
The protein and the gluten content of these wheats deserves a separate discussion. When grown
today, the grains of the wild species usually have high protein contents, in the 16−28% range [2]. It is
very likely that, following domestication, the protein content of wheats has steadily declined because
of the increased starch content. Since the gluten content of wheat is approximately proportional to
the protein content and usually ranges between 70 and 75% of total protein content, it seems that the
earliest farmers were selecting seeds for lower protein and gluten content. Only with the development
of yeast-fermented (leavened) bread baking about 2000−5000 years ago, farmers may have indirectly
begun to select for higher protein content because leavened bread requires a relatively high gluten
content: 10–11% of protein content is considered minimal for bread making. It is possible that this
selection also increased the gluten strength of wheat, measured with the modern W index (Figure 1).
Wheat cultivation methods, along with selection methods, remained substantially the same until the
Second World War. The wheat cultivars introduced during the last centuries before the second World
War are, therefore, defined as heritage varieties, thus diversifying them from the ancient cultivars that
date back to the previous millennia. In addition, heritage varieties usually have higher protein content
respect to modern ones [7].
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After the second World War, two factors radically changed the methods of cultivation and selection
of wheat. The first factor was the great availability of fertilizers (substantially nitrates and phosphates),
deriving from the reconversion of the war industries, while the second historical factor is the beginning
of the industrialization of the processes related to food production. From this moment the main criteria
of grain selection become the high agricultural yield, obtained with the fertilization, and the high
strength of the gluten, required to speed up the industrial procedures related to the processing of
wheat. Another phenomenon that temporally occurred in the same period was wheat dwarfization [8],
to avoid lodging and allow greater weight of the ear. The diminished height of the plant (from 150–180
to less than 50 cm) thus becomes the most evident characteristic that discriminates heritage wheat
from those defined as modern varieties. The other major characteristic, less immediate to be measured,
that discriminates between heritage and modern cultivars is the strength of the gluten, with the W
index passing from values below 100 to values exceeding 300, which speed up both the formation
of the dough and the pasta extrusion processes and at the same time it is responsible of the typical
characteristics of the current wheat products, such as the elasticity of the breads (Figure 1) or the
reduced gelatinization of starches during the pasta cooking [9].
2. Position of the Debate on Ancient, Heritage, and Modern Wheat Nutritional Proprieties
Wheat is the main staple food in many countries, providing a large percentage of daily energy
intake for billions of people. Recently, ancient and heritage wheat cultivars have gained interest
since several clinical studies have suggested that they could represent a healthier choice respect to
modern ones (see Section 4). Although the majority of these studies do not concern patients affected by
CD, it has been suggested that the increase in CD may be related in some way to a different gluten
contained in modern grains [10]. That the serological prevalence of CD is increasing in the last 70
years, regardless of our greater capacity to diagnose it at least in industrialized countries, is a fact
ascertained by independent studies carried out evaluating the CD positivity in blood banks [11–13].
Since the genetic predisposition cannot change in such a short period of time, the increased prevalence
of CD in the last 50–70 years could be associated with the reduction of infant mortality rates due to the
disease [14] or linked to changes in environmental exposures. Nutrition represents one of the major
environmental factors, drastically changed during the last 70 years with the so-called westernization of
the diet [15] but certainly not the only one. In addition to CD, non-celiac gluten sensitivity (NCGS)
has recently appeared among the gluten-related diseases. NCGS was defined for the first time in a
Consensus Conference in 2011 [16]. In addition, in this case, the spreading of the NCGS has been put
in relation to the modern grains and to their different gluten [17], even if it is becoming clear that
the gluten could not be the only responsible for the NCGS and, for this reason, some authors prefer
to define it as non-celiac wheat sensitivity (NCWS) [18]. The current debate, therefore, concerns the
possible differences between modern and heritage or ancient wheat cultivars with regard to human
health and to wheat-related diseases, in particular. This has led to a dichotomy between scientists,
separating those who believe that ancient grains have superior nutritional characteristics from those
who believe that ancient, heritage, or modern wheat are all the same from a nutritional point of view.
Thus, only starting from this two ideological points of view, we can explain the discrepancy between
the conclusions of a study entirely carried out in vitro that states “beneficial properties claimed for old
genotypes are not always sustainable with scientific evidence” [19] and the conclusions of another
study, entirely conducted in vitro that finally “suggest the potential use of old wheat varieties . . .
with health promoting characteristics” [20]. We are convinced that the nutritional characteristics of
a cereal with a very complex composition, and that undergoes profound industrial transformations
before being a food, are not easily deducible from single in vitro studies, and, for this reason, we
propose an overall review of all the studies, including clinical trials on humans, to try to overcome an
ideological separation that can be useful (and exploited) for the food industries but certainly not to the
scientific community.
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3. Differential Nutritional Aspects of Ancient and Modern Wheat Cultivars
3.1. Starch and Glycemic Index
The glycemic effects of whole and ancient cereals have been analyzed in several studies, both on
animals and on humans. A generally accepted hypothesis is that the consumption of whole cereals can
definitely improve their glycemic impact and thus reduce the risk of type 2 diabetes [21], even if some
preclinical studies conducted on animal models of diabetes questions these benefits. For example,
one of these studies compared the impact of 65% whole modern wheat consumption, with modern
refined wheat consumption, considered as a negative control. The reported results showed that the
consumption of whole modern wheat produced modest benefits in the development and progression
of type 2 diabetes in these rats [22]. On the contrary, the introduction of whole wheat made from
ancient cultivars (emmer and einkorn) seems to cause a downregulation of the key regulatory genes
involved in glucose metabolisms and, as a consequence, a significant reduction in insulin levels in rats
after nine weeks of intervention with emmer and einkorn [23]. Consistent with these preclinical results,
clinical studies showed that the complete replacement of modern wheat with the heritage Khorasan
wheat reduced fasting glucose and insulin levels both in healthy subjects and in persons with a high
cardiovascular risk [24,25]. Other diets based on heritage varieties of soft hexaploid wheats, such as
“Verna”, “Gentil Rosso”, and “Autonomia B”, resulted in a significant reduction in blood glucose after
eight weeks of intervention in a double-blinded randomized clinical trial performed on 54 healthy
subjects [26].
Since no differences have been found in the content of starch between heritage or ancient cultivars
and modern ones, a hypothesis aimed at explaining the positive effects on the glycemic control
of ancient and heritage cultivars is that they could have a different ratio between amylose and
amylopectins within their starch [27], in analogy to what happens for the different rice cultivars [28].
This hypothesis, however, has never found sustenance in dedicated scientific studies. Thus, to date,
we do not know exactly how ancient and heritage grains can improve glycemic responses, although
the clinical studies clearly show this diversity. For example, it should be considered that the different
industrial processes which ancient, heritage, or modern cultivar are generally subject to, can also have
effects on postprandial glucose responses [29] (see Section 4).
3.2. Micronutrients
In scientific literature, there is a wide number of papers that shows how different is the
phytochemical composition of the various cultivars of wheat (modern, heritage, and ancient). The
phytochemicals and micronutrients content of wheat is strongly influenced by its genetics but also
and profoundly by the environment and by the interaction between genetics and the environment.
To compare different varieties of wheat, it is, therefore, necessary to cultivate them in the same
environment and in the same year to minimize these important biases [30]. Agronomic and quality
characteristics of old, heritage, and modern wheat varieties were analyzed in a study aimed primarily
at organic farming [31]. The results show that the geographical area, the type of soil, and the climatic
trend are the main variables that determine the different mineral content in the different wheat flours.
Recent studies carried out by Shewry and collaborators, within the “Healthgrain” project,
compared cultivars of ancient and heritage wheat with modern ones, with regard to the content
and composition of bioactive phytochemicals, such as phenolic acids, alkylresorcinols, tocols, sterols,
folates, betaine, and choline. The results of these studies conclude that the ancient and heritage grains
analyzed differ little from the modern cultivars in their content of most bioactive components and may
even be lower in some components, such as dietary fiber [32–34].
Despite this, there are concordant data in the literature on the fact that ancient grains, such as
Einkorn, Emmer, and Khorasan, have a higher content of carotenoids, particularly lutein, selected to
give a yellow color to the grains and flour. Some einkorn cultivars showed lutein content values from
three to eight times higher than modern soft wheat and twice higher than modern durum wheat [35,36].
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The high content of lutein in einkorn could be significant for health in populations that consume
it regularly, since it is characterized by anti-inflammatory and antioxidant properties, particularly
exercised on the retina and on visual function [37]. Furthermore, ancient grains, on average, seem to
contain greater amounts of selenium. This was highlighted in a study that focused on Khorasan wheat
(Kamut® brand) in which the highest selenium content was associated with its antioxidant and type 2
diabetes prevention properties demonstrated in this clinical study [38].
3.3. Polyphenols
Polyphenols are chemical compounds characterized by a phenolic ring and an organic carboxyl
function. They are produced by plants (including wheat) as a physiological response against pathogens
and represent the largest and most complex group of secondary metabolites present in cereals. The
most common polyphenols in cereals are phenolic acids, which may be available in soluble forms
(free compounds or conjugated with sugars) easily absorbed in the human intestine [35,39] or in
insoluble forms, bound to the components of the cell wall. Other polyphenols include flavonoids
(proanthocyanidins and their glycosylated form, anthocyanin), alkylresorcinols, and lignans [40].
Several studies have shown a protective role of polyphenols in human health and, in particular, against
cardiovascular diseases, diabetes, and the metabolic syndrome [41]. A study performed in 2015 [33]
summarizes several data obtained from the analysis of ancient and modern varieties of different
compounds, including phenolic acids. The comparison between modern (soft) wheat and ancient
cultivars (einkorn emmer and spelt) showed a higher average concentration of phenolic acids in ancient
varieties. However, the authors conclude that due to the high variability between samples and in the
analysis methods, these differences should not be considered truly significant. A study conducted in
2011 analyzed the polyphenol content of 16 heritage cultivars and six modern wheat varieties [42],
cultivated in the same geographical location, showing a different polyphenol content profile, with
a greater number of total compounds and isomers observed in six heritage varieties compared to
modern ones. In particular, the Verna, Canove, Carosello, Gentil Rosso, Gentil Rosso Mutico, and
Sieve cultivars showed a higher free polyphenol content than the average measured values, while
the higher polyphenol content was found in the Carosello, Marzuolo D’Aqui, Marzuolo Val Pusteria,
Gentil Rosso, Inallettabile, and Verna varieties but also in two modern varieties, Eureka and Nobel. The
highest value of free flavonoids was found in five heritage varieties (Andriolo, Gentil Rosso Mutico,
Marzuolo D’Aqui, Sieve, and Verna), while the highest values for bound flavonoids were found in the
Gentil Rosso, Gentil Rosso Mutico, Marzuolo D’Aqui, Marzuolo Val Pusteria, and Inallettabile and in
two modern varieties, Eureka and Nobel [42]. Another study in 2019 [43] evaluated the content of
free soluble phenolic compounds of eight heritage varieties (Autonomia, Gentil Rosso, Inallettabile,
Leone aristato, Mentana, Poulard di Ciano, Risciola, and Terminillo) and two modern ones (Bolero and
Blasco). The results showed a higher concentration of phenolic compounds in the heritage varieties
Terminillo, Risciola, Gentil rosso, Mentana, and Leone aristato [43]. Although further analysis are
needed on a larger number of samples and with standardized methodologies, the overall data suggests
that ancient and heritage are qualitatively superior to modern varieties in this aspect. Nevertheless,
considering the role that wheat consumption plays in the human diet, and, in particular, the many other
sources of polyphenols present in the Mediterranean diet (in fruits and vegetables), the differences
observed between wheat varieties may not be relevant in the context of the overall human diet.
3.4. Lipid Profiles
It has been hypothesized that one of the reasons for the improvement of the lipid profile induced by
a diet based on ancient or heritage cultivars in patients suffering from different pathologies is the better
lipid profile of these cultivars, and, in particular, their higher content in mono- and polyunsaturated
fatty acids (MUFA and PUFA) [27]. Although the lipidomics of the grains is rather complex and not
easily simplified with the MUFA and PUFA content, there are experimental evidence that ancient
wheats, such as einkorn, emmer, and spelt, have characteristic lipidomic profiles that are different from
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each other [44]. A study carried out using modern and heritage wheat varieties has revealed differences
between the lipidomic profile of soft grains (Blasco, Bologna, and Virgilio) and that of durum cultivars
(Odisseo, Timilia, Senatore Cappelli, and Miracolo) [45]. However, this study did not reveal significant
differences in the lipid profile between heritage (Virgilio, Timilia, Senatore Cappelli, and Miracolo) and
modern grains (Blasco, Bologna, and Odisseo), while it did not analyze any ancient varieties [45]. It
must be considered that the geographical and agronomic conditions can probably influence the lipid
profile of the wheat. For example, it has been ascertained that nitrogen fertilization is able to modify
the total lipid content and the lipid composition of wheat [46]. Despite this, we can conclude that to
date there is no scientific evidence of differences in lipid composition between heritage and modern
cultivars, while extensive comparative studies of the differences in the lipid profile between ancient
and modern wheats are still lacking. Overall, we can conclude that lipids represent a minor nutritional
component of wheat, despite being important contributors to flour processing and, particularly, for
bread making. In human nutrition, the lipid contribution of cereals is certainly a minority one and it is,
therefore, unlikely that differences on this specific aspect can modify the overall intake in MUFA and
PUFA of a sufficiently varied human diet.
4. Different Food Processing for Different Wheats
With the industrial revolution, wheat-based natural food started to be more and more
processed [47]; today, transformations are become so drastic that highly processed wheat-based
products are routinely consumed in our diet. Since our genetic background is not really adapted to
these severe diet transformations, our physiology is not completely adequate to tolerate the food we eat.
For these reasons, wheat-related disorders have been attributed to these changes: our organism and
digestive physiology could be not adapted to wheat-based foods [48]. In addition to refining, among
drastic and less natural processes applied to wheat, we can also cite higher kneading intensities for
bread baking, the use of baking powder instead of natural leaven, the increased use of extrusion-cooking
at high temperature, and an increased use of additives, such as the vital gluten. Starting from the
beginning, the industrial processes that applied to wheat was the milling. Most of the modern wheat
undergoes a cylinder milling, which leads to the production of refined flours of type 0 and 00 almost
totally deprived of the fiber and the vitamins contained in wheat germ. On the contrary, a good
part of the ancient and heritage wheats are milled in millstones and give rise to wholemeal or less
refined type 1 and 2 flours. In industrial processes for bread baking, leavening powders are often
used instead of natural yeasts. Natural leavening increase digestibility of wheat proteins, including
gluten [49] and other proteins with potential inflammatory effects, such as amylase trypsin inhibitors
(ATI) [50], potentially reducing their immunogenic load (see Sections 5 and 6). In bakery products, vital
gluten (i.e., ‘exogenous’ gluten) can be added to confer technological properties, such as emulsification,
cohesiveness, viscoelasticity, gelation, and foaming. It has been calculated that the intake of vital gluten
has tripled between 1977 and 2012, from 140 to more than 400 g/person/year in the USA [10]. Finally, the
higher temperature industrially adopted for fastening bread baking or pasta drying generally decreases
the wheat protein digestibility [49]. What we can say to highlight differences between products based
on modern wheats and those based on ancient or heritage ones is that modern wheat are much more
frequently subjected to strong industrial processes, while ancient and heritage cultivars are often
processed by using more traditional methods. This is obviously not a rule, but it is what frequently
happens. The ancient or heritage cultivars are often stone-milled and, for the preparation of the bread,
they are leavened using traditional yeasts (S. cerevisiae) or even the sourdough, very rich in lactobacilli
capable of effectively degrading one of the inflammatory components of the wheat proteome: the
ATI proteins [50]. Interestingly, sourdough baking seems to reduce the quantities of both ATIs and
fermentable oligo-, di-, mono-saccharides and polyols (FODMAPs), short chain carbohydrates present
in wheat that are poorly absorbed and contribute to intestinal bloating [51]. On the other hand, modern
grains are often refined and used for the production of processed or ultra-processed foods, with the
addition of additives, such as vital gluten, which drastically worsen their nutritional values, sometimes
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making them fall into the worst category of the NOVA classification for processed food (NOVA 4) [52].
These industrial processes obviously do not depend on the intrinsic nutritional values of the different
wheat cultivars but can certainly improve or worsen their nutritional properties.
5. Studies on Gluten Immune Toxicity
Gluten (from Latin gluten, “glue”) is made by a group of proteins, called gliadins and glutenins,
which localize with starch in the endosperm of wheat. Gluten forms only when glutenin molecules
cross-link via disulfide bonds to form a submicroscopic network attached to gliadin, into the dough [53].
In 2010, van den Broeck and collaborators first analyzed the presence of two gliadin epitopes toxic for
CD patients, defined as Glia-alpha9 and Glia-alpha 20, in a wide selection of ancient, heritage, and
modern wheat cultivars [54]. The modern grains analyzed were originating after the 1980s. The results
of their study were that the Glia-alpha9 epitope was actually more represented in modern cultivars,
despite a rather variable presence within the single groups: ancient, heritage, and modern ones. The
study is certainly remarkable for the large number of cultivars analyzed, while it is certainly reductive
due to the low number of gluten “toxic” epitopes that were analyzed. A more recent study, conducted
by Ribeiro and coworkers in 2016 [55], broadens the spectrum of toxic peptides analyzed to five. The
study analyzes a total of 126 cultivars, divided between ancient, heritage, and modern. The conclusions
of this study were that, on average, the number of toxic epitopes analyzed decreased in the modern soft
wheats compared to the ancient soft ones, while substantially it remained unaffected within the group
of durum wheats. The researchers’ conclusions were, therefore, that the breeding that the wheat has
undergone in the last 100 years did not seem to have increased the quantity of gliadin toxic epitopes.
This conclusion would be also supported by the fact that the selection for a high gluten strength (W)
seems to have acted more on glutenin genes, while most of the peptides toxic for CD patients have
been found in the gliadins. The study conducted by De Santis and collaborators [56] focuses on the
comparison between heritage cultivars released from 1900 to 1949 and modern cultivars obtained from
1985 to 2005 with regard to both glutenin and gliadin content, and with regard to the presence of alpha
and gamma gliadins, considered the most toxic proteins for CD patients. The results of this study were
that in modern cultivars the total amounts of alpha and gamma gliadins did not change, even if a
decrease in omega-5 gliadin was observed. In these modern wheats, however, the glutenin content
increased, with the gliadin/glutenin ratio decreasing from 2.8 to 1.7. One of the hypotheses that has
been proposed is that the selection for gluten strength may have reduced its digestibility. In fact, the
gluten peptides considered “toxic” are formed exclusively during gastric end enteric digestions: If
gliadins and glutenins were degraded to di- or tri-peptides, their immunogenic determinants would
disappear. This hypothesis was firstly tested in a proteomic study [57] that compared five modern
cultivars with five heritage cultivars and only one ancient variety: einkorn (T. monococcum). The result
of this study is that the number of gluten “toxic” peptides, after in vitro digestion, is considerably lower
in einkorn, while the heritage varieties analyzed produced a higher quantity of peptides containing
immunogenic and toxic sequences than modern ones. The results for diploid wheats appear to be
different, and the reduced immuno-toxicity of T. monococcum has been demonstrated in another study
that confirms the better digestibility of this cereal in vitro gluten [58]. Recently [19], a new study, based
on in vitro digestion, has been carried out on nine heritage cultivars, released between the early 1900s
and 1950s, compared with three modern cultivars obtained after 2004. This study concluded that
the digestion of old genotypes generally yielded peptides in greater concentration. In particular, five
peptides of γ-gliadin, known to trigger the adaptive immune reaction, and two peptides of α-gliadin,
known to be toxic to celiac patients, were particularly abundant in some heritage varieties.
It should be emphasized that in vitro digestion systems are models that do not succeed in
reproducing exactly what happens in the intestine. Moreover, since wholemeal flour was subjected
to simulated gastrointestinal digestion, the gluten network was never really studied in these in vitro
digestion experiments. Nevertheless, the hypothesis of a better digestibility of gluten does not seem to
be supported, at least for the heritage varieties.
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In conclusion, the studies carried out on the “toxicity” of gluten, before and after in vitro digestion,
indicate a superiority of ancient diploid varieties (T. monococcum, in particular) but an equal or greater
toxicity of heritage cultivars with respect to the modern ones. It should be added that these studies
concern only one of the gluten-related diseases, namely CD, and that the internationally accepted
guidelines currently provide that these patients should, however, avoid any type of wheat or cereal
containing gluten, including einkorn.
6. Whole Wheat Proteome Immunogenicity
As well as CD is not the only gluten-related disease, gluten are not the only group of wheat
proteins to have immunogenic and potentially negative effects on the intestine. Wheat amylase and
trypsin inhibitors (ATIs) represent a family of up to 17 proteins with molecular weights between 12
and 15 kDa and a variable primary but conserved secondary structure characterized by five intrachain
disulfide bonds and alpha helices. ATIs represent up to 4% of total wheat protein in T. aestivum
(hexaploid) and are highly resistant to intestinal proteases [59]. They are capable of activating Toll
Like Receptor 4, (TLR4), a pro-inflammatory receptor activated by Lipopolysaccharide (LPS) and
other toxins [60]. Relevant biological activity is confined to ATIs in gluten-containing cereals, while
gluten-free cereals display no or minimal activities. ATIs may also act as interfering contaminant of
gluten and have been identified to play a role in the occurrence of a broad range of disorders, including
CD, non-celiac gluten sensitivity (NCGS), and functional gastrointestinal disorders [51,61,62].
In modern hexaploid wheat species, up to 19 different encoding genes for ATIs and similar protease
inhibiting proteins have been identified by complete genome sequencing [63], of which 13 have been
evidenced at protein level in wheat. Two of the most active ATIs, called 0.19 and CM3, showed to have
the highest bioactivity on TLR4-bearing monocytes when extracted from modern exaploid cultivars,
whereas ATI extracts from the hulled wheat species spelt (T. spelta, hexaploid), emmer (T. dicoccum,
tetraploid) showed to have a reduced activity [64]. Furthermore, liquid chromatography-tandem mass
spectrometry (LC−MS/MS) confirmed that einkorn (T. monococcum) contained very low amounts of
ATIs or even none. Even if data on expression and activity of ATIs in heritage wheat are lacking,
what we know so far is that the expression of ATIs (and their variety) seems to increase with ploidy
and is, therefore, greater in hexaploids (T. aestivum) than in tetraploids (T. durum), while diploids
(einkorn) have a very low ATIs expression. In an in vitro study on ATIs activity, measured as IL-8
secretion in myeloid cells, it was shown that spelt (T. spelta, hexaploid) could be an exception since
authors detected lower, even if not significant, ATIs activity in this ancient hulled wheat cultivar [62].
A recent proteomic study on ATIs expression casts doubt on this datum and instead measured a higher
expression of ATIs in spelt than in other modern hexaploid cultivars [65]. However, this work also
confirms the evolutionary increase of the total expression of ATI proteins with increasing ploidy.
The inflammatory potential of the total wheat proteome was tested in vitro, using peripheral
blood leukocytes obtained from patients diagnosed with NCGS. In a first study [17], two heritage
varieties were compared with two modern ones, and a lower synthesis of a chemokine related to the
intestinal permeability and inflammation (CXCL10) was observed in leukocytes treated with heritage
cultivar extracted proteins. One of this cultivar was the Khorasan wheat (T. turanicum, tetraploids),
where ATIs proteins resulted to have a lower pro-inflammatory activity in myeloid cells in the study
by Zevallos and coworkers [62]. Similar results on CXCL10 secretion were obtained in a second study
on pediatric NCGS patients [66], in which two heritage varieties were compared to a modern one.
7. Wheat Cultivars and the Microbiome
Intestinal human microbiota is involved in several metabolic processes besides the well-known
role in gut-associated immune system homeostasis. Wheat proteins, such as gluten and ATI, are only
partially digested by intestinal proteases but can be effectively degraded by intestinal microbiota
in a complex interaction that can have an impact on both peptide immunogenicity and microbiota
composition and that certainly affect the risk of developing disorders related to wheat (A). Indeed, it
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has been demonstrated that wheat peptides after microbial digestion can have an increased or reduced
immunogenicity depending on the degrading bacteria. Pseudomonas aeruginosa, an opportunistic
pathogen detected in CD patients, is able to further degrade protease-generated gluten peptides in
smaller fragments with immunogenic sequences and a higher ability to translocate trough the epithelial
barrier and thus interact with the gut immune system. On the other hand, Lactobacillus spp., which
is highly represented in healthy subjects, is able to decrease the immunogenicity of wheat peptides
generated by human or bacterial digestions [67,68]. Partially digested gluten peptides constitutes
a substrate for other gut bacteria, such as Rothia spp. [69]. Since it is well known that the intestinal
microbiota is susceptible to food components, the general quality of food and the specific quality
of wheat could affect the gut microbiota ecology. Human studies showed changes in the amount
of bacterial family and species linked to whole wheat consumption. In particular, an increase in
Bifidobacterium, Lactobacillus, Enterococcus, and Prevotella species [70,71] and a decrease of Dialister,
Blautia, and Collinsella [71] have been linked to whole wheat consumption, even if no changes resulted
at genus or higher taxonomic levels [71,72]. However, while providing interesting data taken as a
whole, these studies show a strong heterogeneity in the experimental design and in the methods used,
as pointed out by Koecher and collaborators [73]. As for heritage grains, a single study showed an
overall positive effect of Khorasan whole wheat on the microbiota, when compared to modern whole
wheat. In particular, in healthy volunteers, the Khorasan-based diet showed a tendency to decrease in
Bacteroides/Prevotella, associated with an increased release of short chain fatty acids [74]. The role of
the consumption of whole wheat and, in particular, of ancient or heritage cultivars on the microbiota
ecology must be further studied in vivo, above all focusing on the pathological conditions, and, in
particular, the functional intestinal disorders and the wheat-related diseases.
An in vitro, study conducted on soluble fiber extracted from heritage or modern wheat varieties
has attempted to highlight differences in their prebiotic properties. Soluble fibers were added to
cultures of B. pseudocatenulatum and L. plantarum, and the results showed that both the soluble fiber
of heritage and modern cultivars had a good prebiotic activity [75]. An in vivo study conducted on
pigs, fed for 30 days with a diet including T. monoccum or standard modern wheat, showed changes in
the microbiota of pigs fed with this ancient cultivar. In particular, an enrichment in the short-chain
fatty acids producing bacteria (genera Blautia, Faecalibacterium, and Oscillospira) associated with an
increased metabolic and microbial diversity was observed in pigs fed with T. monococcum but not in
those fed with modern wheat, suggesting a strong beneficial prebiotic effect of this ancient variety on
the health of the intestinal ecosystem [76].
8. Ancient and Heritage Wheat in Clinical Study
To date, there are some relevant studies conducted on human beings aimed at testing the effect
of consumption of different varieties of wheat, and, in particular, heritage and ancient, on diabetes,
cardiovascular diseases, Nonalcoholic Fatty Liver Disease (NAFLD), and gastroenteric disorders,
such as Irritable Bowel Syndrome, Non-Celiac Gluten Sensitivity, and also CD. In all these studies,
enrolled patients were asked to replace all the grain sources usually consumed with those specifically
intended for the study, which were well characterized and standardized in terms of quantity and
nutritional properties. Many of these studies have been focused on the heritage variety Khorasan
(Kamut® brand). This is due to the fact that this multinational company has invested heavily in
terms of scientific research. However, this does not diminish the importance of these studies or their
scientific value. A pilot study conducted on 21 patients with type 2 diabetes mellitus (T2DM) showed
that the replacement of modern wheat with Khorasan wheat for eight weeks was able to significantly
reduce insulin and glucose levels with respect to modern wheat consumption [77]. In 2017, a second
study carried out on 30 healthy volunteers confirmed the nutritional properties of Khorasan. Healthy
volunteers were randomized to follow a Khorasan-based diet or a modern grain-based diet [38]. After
16 weeks, the group following the Khorasan-based diet had significantly reduced fat mass and blood
insulin levels, while showing higher levels of docosahexaenoic acid (DHA), a polyunsaturated fatty
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acid considered protective against the onset of diseases, such as diabetes, coronary heart disease, and
even cancer [78–80]. A randomized crossover study of 22 healthy subjects demonstrated a protective
role for Khorasan wheat consumption in cardiovascular disease. Eight weeks of diet based on this
heritage cultivar resulted in a significant reduction in total cholesterol, LDL, and glucose [24] in the
blood. A decrease in triglycerides and fasting plasma glucose was observed in a randomized, crossover
clinical trial on 63 healthy volunteers [81]. Furthermore, a randomized crossover study conducted on
22 patients suffering from acute coronary syndrome confirmed the results, showing again a decrease in
blood levels of total cholesterol, LDL-C, fasting glucose, and insulin that were not observed after the
consumption of modern cultivars [25].
A particularly interesting study involved 40 patients diagnosed with NAFLD [82]. In this
randomized double-blind study, patients followed a diet based on Khorasan wheat as the sole source
of wheat (pasta, bread, crackers, biscuits) or a diet based on modern grains (pasta, bread, crackers,
biscuits) for a period of three months. The results of this study showed that in the Khorasan group
alone there was a significant decrease in alanine aminotransferase (ALT), aspartate aminotransferase
(AST), and alkaline phosphatase blood levels, three significant markers of liver function. Furthermore,
cholesterloemia was also found decreased in the Khorasan group. From an inflammatory point of view,
however, significant decreases were observed in some pro-inflammatory circulating cytokines, such as
IL-1ra, IL-8, and Tumor necrosis factor alpha (TNF-α), in NAFLD patients after the dietary intervention
with the Khorasan heritage wheat [82]. A systemic anti-inflammatory effect of Khorasan wheat
consumption was also detected by our group in a recent randomized crossover pilot study involving
20 professional or semi-professional athletes [7]. In our study, after four weeks of a Khorasan-based
diet, a significant reduction in blood levels of the Monocyte chemoattractant protein 1 (MCP-1), a
pro-inflammatory chemokine produced by muscle during strenuous activity, was recorded.
One of the most interesting studies has compared the effects of nutrition based on three heritage
cultivars (Verna, Gentil Rosso, and Autonomia B) to that based on a modern wheat (Blasco) [26]. In
this study, 45 healthy subjects were randomized into groups fed with wheat from a single cultivar.
Furthermore, this study compared the same cultivars produced by conventional agriculture and
by organic farming. The results of this study demonstrate once again that the consumption of
heritage varieties has led to a significant blood reduction of total cholesterol, LDL cholesterol, and
glucose, which was not registered after the modern wheat-based diet. It is interesting to note that no
experimental differences were found between the grains from organic cultivation and those obtained
with conventional agriculture and that, therefore, the differences were attributable to different genetic
and nutritional characteristics of the grains. Two human studies instead focused on gastrointestinal
disorders, particularly on irritable bowel syndrome (IBS) and CD. The first study was a randomized
double-blind study of 20 subjects who were randomly assigned to switch from the modern wheat-based
diet to a Khorasan-based diet. During the intervention period with Khorasan wheat-based products,
IBS patients showed a significant reduction in symptom severity associated with a decrease in serum
levels of pro-inflammatory cytokines, such as IL-6, IL-17, interferon-γ, and MCP-1, cytokines and
chemokines that in some studies were found to be higher in the IBS patient population than in healthy
controls [83]. The second clinical study instead involved only eight CD patients which were following
a gluten-free diet and were asked to eat biscuits made with the ancient wheat T. monococcum for 60
days [84]. Although the study confirmed the toxicity of this variety for patients with CD from a
histological and serological point of view, this ancient variety of wheat was clinically well-tolerated,
suggesting a potential efficacy in patients suffering from other gluten-related diseases, such as NCGS.
Table 1 summarizes all the clinical trial so far conducted on ancient or heritage wheat cultivars. At
clinical level, these studies, in agreement with each other, demonstrate that the main effects on humans
of which these grains are capable seem to be those antioxidants and anti-inflammatories, which as a
consequence lead to beneficial effects on metabolic and clinical parameters.
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9. Conclusions and Future Directions
The analysis of recent literature makes clear differences between the so-called ancient grains,
those released before the 1950s (defined as heritage), and the modern cultivars. From the macro- and
micronutrient composition point of view, the studies conducted so far do not reveal huge differences
between the wheat cultivars of different ages, even if the content in secondary metabolites and in
polyphenols seems higher and more varied in older cultivars. In addition, with regard to micronutrients,
various studies suggest that there may be differences, especially in terms of mineral content, with an
advantage of older wheats. As far as the protein component is concerned, ancient or heritage cultivars
tend to have, at the same crop conditions, a higher content in proteins, and, therefore, in gluten, but
they have a completely different gluten quality with a very weaker structure and strength. In fact, the
W values of the modern wheats are always 2–3 times higher than all their predecessors, since the high
W value has been one of the central criteria that guided the wheat selection from 1940–50 onwards.
Despite this big evolutive diversity, there does not seem to be any difference between heritage and
modern wheats in the production of immunogenic and toxic gluten peptides, although these type
of in vitro studies have non-negligible biases. The ancient grains instead, and, in particular, the T.
monococcum, showed a less toxic and more digestible gluten, although they remain still ineligible for
CD patients. In addition, with regard to the ATI immunogenic proteins and peptides, there is no doubt
that these are much less expressed in ancient grains, while it is still controversial to consider the fact
that they could also be less expressed in heritage cultivars.
Despite these differences, which appear quite modest at the nutritional level, when the flours or
their extracts are added to cell cultures, the differences between ancient or heritage grains and modern
ones become more easily detectable [85]. When switching to clinical trials, performed on patients
and on healthy subjects, all doubts disappear and diets based on ancient or heritage cultivars always
showed clear advantages in terms of anti-inflammatory and antioxidant activities. The limit of these
studies are certainly the low number of cultivars tested so far and, sometimes, the low number of
subjects enrolled. Despite this, considering the results of all the available trials (Table 1), it could be
said that modern grains, when clinically tested, clearly showed pro-inflammatory and pro-oxidant
activities even if, from a molecular point of view, we do not yet know what these negative health
activities are due to. Continuing to affirm that, from a nutritional point of view, modern, ancient, or
heritage wheats are all the same, means deliberately ignoring all the clinical studies conducted so far.
From a commercial point of view, these healthier nutritional properties of ancient and heritage
grains have been overly exploited, even though in many countries there are no wheat chain controls
aimed at guaranteeing consumers that the grains indicated as heritage or ancient on the packaging
of the products are really of those types. Furthermore, the quantities of ancient and heritage wheats
really produced would probably not guarantee the current production of self-declared “ancient wheat
based” foodstuff.
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Table 1. Human intervention trials on ancient or heritage cultivars performed on healthy or diseased subjects.
Inclusion Criteria Experimental Design No. of SubjectEnrolled
Ancient/Heritage
Wheat Varieties Control Wheat
Duration of
Intervention
Recorded Effects
(Ancient/Heritage vs. Control) Ref.
Type 2 Diabetes Mellitus.
Randomized, parallel groups.
Enrolled patients were
randomized to follow an
ancient/heritage grain-based
diet or a modern grain-based
diet.
22
(8 m, 14 f), age:
42–71 years.
Whole grain flour:
Triticum dicoccum.
Whole grain flour:
Triticum aestivum
(modern).
6 weeks.
Decreased blood total
cholesterol, triglycerides, and
LDL-cholesterol.
[86]
Healthy subjects. Open label.
11
Men, mean age: 25
± 2.
Triticum
monococcum
(Einkorn Bread).
Triticum aestivum
(modern).
One single meal
test.
Decreased Gastric Inhibitory
Peptide (GIP) with einkorn
bread.
[87]
Healthy subjects.
Non-blinded, crossover.
Enrolled patients were
randomized to follow a heritage
grain-based diet or a modern
grain-based diet.
20
(11 m, 9 f),
median age 39.5
years.
Semi-Whole grain:
Triticum aestivum
Verna.
Semi-Whole grain:
Triticum aestivum
mixed modern
varieties.
10 weeks of diet
intervention.
Decreased blood total
cholesterol, LDL-cholesterol,
IL-8, whole blood viscosity.
[88]
Baker’s asthma or wheat
allergy.
Interventional open label: Oral
and bronchial challenges, prick
test.
66
(45 m, 21 f), mean
age: 28.6 ± 12.9
years.
Triticum spelta
grain extracts.
Triticum aestivum
grain extract. Immediate.
Decrease of wheal area and
percentage of positive challenge
tests.
[89]
Healthy subjects.
Randomized, single blind,
crossover.
Enrolled patients switched from
heritage grain-based diet to
modern grain-based diet.
22
(8 m, 14 f) mean
age: 50.5 ± 11.8
Years.
Semi-Whole grain:
Triticum turgidum.
Khorasan.
Mix of semi-Whole
grain:
Triticum durum and
Triticum Aestivum
(modern).
8 weeks diet
intervention.
Decrease of blood total
cholesterol, LDL-cholesterol,
glucose, TNFα, IL-6, IL-12, and
Vascular endothelial growth
factor (VEGF).
Increase: K+, Mg2+.
[24]
Healthy subjects.
Randomized, single-blinded,
crossover trial.
Enrolled patients switched from
heritage grain-based diet to
modern grain-based diet.
20
(11 m, 9 f), age:
21–61 years.
Mean BMI:
26.1 ± 2.5 (m)
24.8 ± 4.9 (f)
Semi-whole grain:
Triticum durum
Senatore Cappelli.
Mixed modern
semi-whole grain
Triticum durum
wheat varieties
10 weeks diet
intervention.
Decrease of total cholesterol,
whole blood viscosity, and Red
Blood Cell deformability.
[90]
Celiac Disease (CD)
patients. Single blind, crossover trial.
12
(4 m, 8 f) mean age:
44.5 ± 10 years.
Triticum
monococcum.
Amygluten (pure
gluten) and rice.
Administration of
a single dose. No significant conclusions. [91]
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Table 1. Cont.
Inclusion Criteria Experimental Design No. of SubjectEnrolled
Ancient/Heritage
Wheat Varieties Control Wheat
Duration of
Intervention
Recorded Effects
(Ancient/Heritage vs. Control) Ref.
Irritable Bowel Syndrome
(IBS) patients
(Rome III Diagnostic
Criteria).
Randomized, double-blinded,
crossover trial.
Enrolled patients switched from
ancient/heritage grain-based
diet to modern grain-based diet.
20
(7 m, 13 f),
median age 35.5
years.
Semi whole grain:
Triticum turgidum
Khorasan.
Modern Italian
durum and soft
wheat varieties.
6 weeks diet
intervention.
Decrease in the severity of IBS
symptoms (abdominal pain,
bloating, stool consistency, and
tiredness). Decrease of IL-6,
IL-17, Interferon gamma
(IFN-γ), Monocyte
chemoattractant protein 1
(MCP-1), VEGF.
[83]
Healthy subjects. Parallel arms.
30
(4 m, 26 f), mean
age: 37 ± 7 years.
Whole grain
Triticum turgidum
Khorasan.
whole grain:
Triticum durum. 3 months.
Increase of short chain fatty
acids (SCFA), phenol
compounds and an increase in
health-promoting mutualists in
the gut microbiota.
[74]
Type 2 Diabetes Mellitus.
Randomized, double blind,
crossover.
Enrolled patients switched from
ancient/heritage grain-based
diet to modern grain-based diet.
24
(14 m, 7 f), mean
age 64.4 ± 10.9
years.
Semi-whole grain:
Triticum turgidum
Khorasan.
Mix of semi-whole
grain: T. durum
and T. aestivum
(modern varieties).
8 weeks diet
intervention.
Decrease of blood total and
LDL cholesterol, insulin and
fasting glucose. Decreased
levels of reactive oxygen species
(ROS), VEGF, and IL-1ra.
[77]
Acute Coronary
Syndrome.
Randomized, double-blinded,
crossover trial.
Enrolled patients switched from
heritage grain-based diet to
modern grain-based diet.
22
(13 m, 9 f), median
age 61 years.
Semi whole grain:
Triticum turgidum
Khorasan.
Mix of semi-whole
grain: T. durum
and aestivum
(modern).
8 weeks diet
intervention.
Decrease of blood total
cholesterol, LDL-cholesterol,
fasting glucose, insulin ROS,
and TNF-α.
[25]
Healthy young athletes.
Randomized, single-blind
crossover trial.
Enrolled patients switched from
ancient/heritage grain-based
diet to modern grain-based diet.
20,
men,
median age
18.3 (15–25) years.
Semi whole grain:
Triticum turgidum
Khorasan.
Semi-whole grain:
Triticum turgidum
ssp. durum,
Triticum aestivum
(modern).
4 weeks diet
intervention.
Decrease of MCP–1 and
improvement of self–rated
health status.
[7]
CD patients in remission
and in GFD diet. Phase II, open label.
7
1 man, 6 women,
median age 37 ±
7.3 years
Triticum
monococcum. None. 60 days.
Increased villous atrophy and
recurrence of dermatitis
herpetiformis.
[84]
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Table 1. Cont.
Inclusion Criteria Experimental Design No. of SubjectEnrolled
Ancient/Heritage
Wheat Varieties Control Wheat
Duration of
Intervention
Recorded Effects
(Ancient/Heritage vs. Control) Ref.
Healthy subjects.
Randomized, double-blinded,
crossover trial.
Enrolled patients switched from
heritage grain-based diet to
modern grain-based diet.
Three diet intervention studied:
1. Verna
2. Blasco
3. Gentil Rosso or Autonomia B.
45
32 men, 13 women,
median age
50.1 (25–75) years.
Triticum aestivum:
Verna,
Gentil Rosso,
Autonomia B.
Triticum aestivum:
Blasco (modern).
8 weeks diet
intervention.
Decrease of blood total
cholesterol, LDL-cholesterol,
and fasting glucose.
[26]
Pre-hypertensive non
diabetic adult volunteers
with no metabolic,
cardiovascular,
gastrointestinal, nor
endocrine major
disorders.
Double-blind, randomized,
feeding-controlled, crossover.
Enrolled patients switched from
heritage grain-based diet to
modern grain-based diet.
63
(30 m, 33 f), mean
age
55.9 ± 6.8 years.
Triticum turgidum
Khorasan.
Mix of T. durum
varieties and T.
aestivum
(modern).
4 weeks diet
intervention.
Decrease of blood triglycerides,
fasting glucose, systolic blood
pressure, and rise of pulse
volume change.
[81]
Nonalcoholic Fatty Liver
Disease (NAFLD)—mild
to moderate liver
steatosis—NO, excessive
alcohol consumption,
type 2 diabetes mellitus
(T2DM), viral hepatitis,
NASH, and chronic liver
diseases.
Randomized, double-blinded
trial with two parallel arms.
Enrolled patients were
randomized 1:1 to follow an
heritage grain-based diet or a
modern grain-based diet.
40
(12 m, 28 f), mean
age 55.2 ± 10.4
years.
Semi whole grain:
Triticum turgidum
Khorasan.
Mix of semi-whole
grain: T. durum
and T. aestivum
(modern).
3 months.
Decrease of alanine
aminotransferase (ALT),
aspartate aminotransferase
(AST), TNF-a, IL-1ra, IL-8, and
IFN-γ.
[82]
Healthy subjects.
Randomized, non-blind,
parallel arm study. Enrolled
patients were randomized 1:1 to
follow an ancient/heritage
grain-based diet or a modern
grain-based diet.
30
median age 37
years.
Whole grain:
Triticum turgidum
Khorasan.
Mix of whole grain
modern
commercial Italian
durum wheat.
16 weeks.
Decrease of fat mass and blood
insulin; increase of
docosahexaenoic acid (DHA).
[38]
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